Merit Medical Systems, Inc. has completed the acquisition of the C2 CryoBalloon™ device and related technology from Pentax of America, Inc., a subsidiary of PENTAX® Medical, Inc. The transaction follows a definitive asset purchase agreement between the parties, with the deal closing on November 3, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merit Medical Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000856982-25-000058), on November 03, 2025, and is solely responsible for the information contained therein.